Presentation is loading. Please wait.

Presentation is loading. Please wait.

E2F4 program is predictive of the efficacy of intravesical BCG immunotherapy in NMIBC. A, the survival curves of intravesical therapy-treated and untreated.

Similar presentations


Presentation on theme: "E2F4 program is predictive of the efficacy of intravesical BCG immunotherapy in NMIBC. A, the survival curves of intravesical therapy-treated and untreated."— Presentation transcript:

1 E2F4 program is predictive of the efficacy of intravesical BCG immunotherapy in NMIBC. A, the survival curves of intravesical therapy-treated and untreated groups are compared all in A, E2F4>0 (B), and E2F4<0 NMIBC samples (C). E2F4 program is predictive of the efficacy of intravesical BCG immunotherapy in NMIBC. A, the survival curves of intravesical therapy-treated and untreated groups are compared all in A, E2F4>0 (B), and E2F4<0 NMIBC samples (C). IVT: intravesical BCG immunotherapy. Chao Cheng et al. Mol Cancer Res 2015;13: ©2015 by American Association for Cancer Research


Download ppt "E2F4 program is predictive of the efficacy of intravesical BCG immunotherapy in NMIBC. A, the survival curves of intravesical therapy-treated and untreated."

Similar presentations


Ads by Google